Good morning. Welcome to EnWave Corporation's Q2 2024 earnings conference call. My name is Daryl, and I will be your operator for today's call. Joining us for today's presentation are the company's President and CEO, Brent Charleton, and Dylan Murray, EnWave's CFO. As a reminder, all participants are in a listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Finally, I would like to remind everyone that this call will be made available for replay via a link in the Investor Relations section of the company's website at www.enwave.net. Now, I would like to turn the call over to EnWave's CEO, Mr. Brent Charleton. Sir, please proceed. Thank you, and thanks to all of you who have joined us today to discuss EnWave Corporation's Q2 performance and our outlook for the rest of fiscal 2024. Now, consistent with past quarterly earnings calls, the information we will present today contains forward-looking information that is based on our management's expectations, estimates, and projections. Our statements are not a guarantee of future performance and involve a number of risks, uncertainties, and assumptions. Please consider the risk factors in the filings made by EnWave on SEDAR when reviewing this information. Also, all amounts discussed will be in Canadian dollars unless otherwise noted. EnWave's second fiscal quarter of 2024 has effectively set the stage for stronger performance throughout the remainder of 2024 and beyond. We continued to achieve positive momentum in our royalty growth, but we were unable to complete new purchase orders for radiant energy vacuum machinery from new or existing royalty partners prior to the completion of the quarter. However, earlier this week, we confirmed a new 120-kilowatt purchase order from an existing royalty partner to support their need for increased manufacturing capacity, tied to opportunities with several major consumer packaged goods brands. And then, this morning, we announced a second large-scale REV machine sale, the second in one week. The deal announced this morning is a sale of the 100-kilowatt machine that was previously being used by NutraDried and was not included in the asset sale of the Moon Cheese brand and certain other machinery to Creation Foods earlier this year. This 100-kilowatt sale to BranchOut Food will yield a very healthy margin profit to EnWave and allow BranchOut Food to ramp up production capacity for their line of snack products very quickly. BranchOut Food has enjoyed tremendous sales success in recent months. Further to these two deals, we are well advanced on a number of similar opportunities that could be confirmed this fiscal year. If these opportunities come to fruition, we expect to deliver an exceptionally better second half of the fiscal year. Royalty growth continues to be a strong quarter-over-quarter, and this is the key metric that investors should continue to focus on. As we continue to grow our diversified portfolio of royalty streams, we will get closer to covering our baseline expenses, and we will become less susceptible to machine sales and their impacts on revenue, margins, and EBITDA quarter to quarter. In regards to expense control, we've been diligent in maintaining a reasonable structure and have been extremely critical regarding discretionary spending. In Q2, and to the date of this call, we did close 2 new technology evaluation agreements, one with a US-based cannabis company and one with a company led by a Michelin Star chef. The cannabis agreement is expected to conclude in June, when the evaluating company will decide to move forward with REV machinery acquisition or not. The evaluation associated with the Michelin Star chef is expected to continue through Q4, as they have a more robust new product development plan. We also signed a new commercial license in Q2 with an established South American food company. They agreed to lease two 10-kilowatt machines for initial product development and commercial sales. Unfortunately, it took this company until May to coordinate the receipt of these machines due to unforeseen tax issues. We expect this project to intensify in the coming months, and a decision from this licensed royalty partner regarding large-scale machinery in calendar 2024. One additional bright spot in Q2 was the confirmation of a material toll manufacturing contract with BranchOut Food, a current royalty partner who is growing its business significantly, to use our REVworx facility to produce Brussels sprouts for their snack portfolio. We have been producing products for BranchOut Food since March and expect to continue production until August, if not longer. There is a high likelihood that additional orders will be confirmed due to large repeat orders from BranchOut's customers, extending the engagement at REVworx longer term. We have other companies scheduled for line trials this summer, and we are optimistic regarding additional utilization of REVworx beyond this large current contract. Looking forward now to the rest of Q3 and Q4, the efforts of our team throughout Q2 has laid the groundwork for multiple 10-kilowatt and large-scale machine sale opportunities. Repeat orders from existing royalty partners, new licensees, and research and development organizations are all possible. Some of these projects are focused on new commercial product areas, including pet treats, seafood products, and cosmetic applications. And as indicated by our royalty growth, several of our key royalty partners are enjoying increased success in market, and we believe this should continue. The aforementioned recently announced a 120-kilowatt machine sale to an existing royalty partner, and then 100-kilowatt machine sale to BranchOut Food, clearly welcome Q3 steps forward in the right direction. Our expectations is that the machine should reach full capacity utilization in 2025, as the purchaser has many high-volume toll manufacturing projects lined up. This is the 120-kilowatt machine. It's possible that we could see another large-scale order from that same partner within the next 12 months based on their current pipeline. Now, over the past 3 years, EnWave has sold between 4 and 6 large-scale REV machines per year. With the opportunities identified and sales efforts invested year to date, we believe we are well positioned to yield similar performance in fiscal year 2024. Events of fiscal Q2 have confirmed for us that the market interest for REV technology is strong and that sales opportunities are therefore robust. It also suggests to me that there may be an opportunity to invest in and potentially expand our internal sales structure to tighten sales cycles and potentially increase EnWave's annual large machine sales cadence from 4-6, as it has been historically, to 8-10 machines. While more assessment work is required, we've identified certain international markets where we may be able to expedite sales opportunities with strategic in-market hires. I will share more details on the results of our assessment and our growth plans in the coming months. However, there's no question that now is the time to drive growth, and having a more robust sales structure in place should help improve EnWave's future performance. Our technology is advanced, the commercial success of many of our royalty partners is evident, and our pipeline of blue-chip prospects is growing. I'll now ask Dylan to summarize EnWave's detailed quarterly financial performance. Thanks, Brent. Good morning, everyone, and thank you for joining us today. Please note that the figures I'll be going over today can be found in our press release from yesterday and in the financial statements in MD&A filed on SEDAR, and all amounts are in Canadian dollars unless otherwise noted. I will make reference to Adjusted EBITDA, which is a non-IFRS financial measure, so please refer to the non-IFRS financial measure disclosures and reconciliation to GAAP net income, both in the press release and our MD&A. Also, please note that the comparative period I'll refer to throughout this presentation is the prior-year Q2 ended March 31, 2023. Revenues for Q2 were CAD 663,000, compared to CAD 4.64 million in Q2 2023, a decrease of CAD 3.97 million or 86%. The decrease was primarily related to fewer machine sales and machines in fabrication during the period, and two machine flips in the comparative period. The decrease in revenue was partially offset by third-party royalty revenue, which was CAD 414K in Q2 2024, compared to CAD 277K in Q2 2023, an increase of CAD 137K or 49%. Royalties grew due to increased partner product sales and production. And as our royalty partners grow their businesses and increase capacity utilization on REV equipment alongside new REV installations arising from new sales, we hope to see material royalty growth over the coming quarters. Gross margin for the company in Q2 2024 was -25%, compared to 49% in Q2 2023. The decrease in margin was a result of no new machine sales and fewer machines in fabrication to absorb fixed overhead costs and two strategic machine redeployments in the comparative period. SG&A expenses, including R&D, were CAD 1.39 million for Q2 2024, which was consistent with the comparable period in the prior year. As Brent mentioned, the company continues to make concerted efforts to manage its discretionary spending. Adjusted EBITDA is a non-IFRS financial measure, so please refer to our MD&A for the reconciliation from GAAP net income to adjusted EBITDA. The company reported an adjusted EBITDA loss of CAD 1.27 million for Q2 2024, compared to an adjusted EBITDA profit of CAD 1.15 million for Q2 2023, a decrease of CAD 2.42 million. The decrease in Adjusted EBITDA was primarily related to no new machine sales and fewer machines in fabrication during the period and the two strategic redeployments in the comparative period. We finished the quarter with cash and cash equivalents of CAD 3.16 million and a net working capital surplus of CAD 6.31 million as at March 31. Our balance sheet remains debt-free. Thank you, Dylan. As I mentioned earlier, there was a lot of positive groundwork and sales efforts completed in fiscal Q2 that are not reflected in today's numbers. However, Q2 has positioned EnWave for materially better results in the back half of the year. Additionally, we have identified opportunities to expand our sales structure, as mentioned, and increase our sales cadence in the coming quarters. I'd now like to open up the call for your questions. Operator, please provide the appropriate instructions. Thank you. At this time, we will be conducting a question-and-answer session. If you would like to ask a question, please press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press Star two if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. If you have joined us via the webcast, please refer to the Ask a Question text box on your webcast player to submit questions there. If there are any outstanding questions at the end of the call, the company will be happy to take them by email at ir@enwave.net. One moment please, while we poll for your questions. Our first questions come from the line of Bart Goemaere with Beurs Tips. Please proceed with your questions. Hi, this is Bart Kumar from Bear Tips in Belgium. Congratulations, Brent, with the recent machine wins. Always feels good to see that the new orders are coming in. I have some questions about in the MD&A that was stated in the machine fabrication and installation pipeline. We see that there are multiple machines waiting for installation in the cannabis industry, especially in the United States. Could you shed some light on when do you think those machines are going to be installed? Sure, Bart. So going from that list of different partners that have machines on hold for commissioning, we recently completed the 120-kilowatt commissioning at Bridgford Foods, which was the machine that was funded by the U.S. Army. That is now commercially running, not only for the development and future consistent production of cheesecake components for military rations, but is also now being engaged for some line trial work and potential co-manufacturing from other businesses that we've engaged with, which should therefore drive royalty growth over the next 12 months. The 120 kilowatts that was purchased as a second unit by a U.S. cannabis partner has yet to be installed, and this is tied to their incompletion of a facility which it was tabbed for. So the determination of where that machine goes at this point is still TBD, and we are waiting for them to provide further instructions. Some of the 10-kilowatt units that are still on the commissioning list to be installed, actually, in Australia for, again, cannabis companies, one of which we just recently got instructions on timing for a completion of the install this year, and the other one is undetermined. As you can imagine, some of these companies are struggling financially. I believe I've covered up the main ones, but if there's any specific machine you'd like more information on, we're happy to provide context. Okay. And, secondly, do you still need to receive money from, let's say, the sale of the machinery and other goods of NutraDried, or do you, do you still need money from the U.S. government? So, in terms of outstanding money sold from Creations on that repatriated 100-kilowatt machine, there's about $500,000 outstanding. And then the second part in terms of, you know, expected IRS checks, there's still, we'll call it another $500,000-$700,000 that is outstanding, that we have not received and have not recognized for financial reporting purposes until we receive confirmation directly from the IRS. But that's coming. I think we may have lost Bart there. Bart, are you still connected with us? Okay, it looks like Bart did drop out, so, I'm gonna pass the call back over to Brent Charleton, CEO, to answer any questions submitted via the webcast and for closing remarks. Okay, thanks so much. There's one question that's being submitted via the webcast, and it was a question about buying back shares. Currently, we are not employing a buyback program. We haven't executed any buybacks, so all the buying right now is through a third party, but we maintain our right to utilize the plan that's been put in place at an appropriate time when we see fit. And with that, I'll thank everybody for joining us for today's conference call. Again, we're available post-call to answer any questions that you may have, either via email or telephone call. At this time, you may now disconnect.